EN
HI
Summary
As of 5 Nov, 2026, Supriya Lifescience stock price is ₹880.4. During the trading session, the stock has moved between an intraday low of ₹857.30 and an intraday high of ₹882.30. Over the last 52 weeks, Supriya Lifescience has traded between ₹545.50 and ₹1085.00.
The stock has recorded a trading volume of 81,359 shares,. Its Average Traded Price (ATP) is ₹871.60, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 200 @ ₹880.40.
Supriya Lifescience has an upper circuit limit of ₹1031.85 and a lower circuit limit of ₹687.95. The total value traded stands at ₹7.09 CR, and the delivery percentage for the day is 41.65%.
The stock is currently traded with a market lot size of 1. Supriya Lifescience also offers a dividend yield of 0%.
Supriya Lifescience Share Price Chart
Supriya Lifescience Share Key Metrics
Volume
81359.00
Market Cap
6920.72 CR
LTQ@LTP
200@880.40
ATP
871.6
Var Margin
23.15 %
Circuit Range
687.95-1031.85
Delivery %
41.65 %
Value
7.09 CR
ASM/GSM
No
Market Lot
1
Supriya Lifescience Resistance and Support
Pivot 848.38
Resistance
First Resistance
876.51
Second Resistance
893.13
Third Resistance
921.26
Support
First Support
831.76
Second Support
803.63
Third Support
787.01
Supriya Lifescience Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Nov 05 2026 | 873.95 | 880.4 | 2.38% | 882.3 | 857.3 |
| Wed Nov 04 2026 | 836 | 859.9 | 3.26% | 865 | 820.25 |
| Tue Nov 03 2026 | 844.95 | 832.79 | -0.65% | 849.79 | 826.5 |
Supriya Lifescience Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-06 | Quarterly Results |
| 2026-08-13 | Quarterly Results |
| 2026-05-27 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-27 | Audited Results & Final Dividend |
| 2025-03-10 | Others |
| 2025-01-24 | Quarterly Results & Others |
| 2024-10-28 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Supriya Lifescience News
Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Quarter And Half Year Ended September 30, 2026
Supriya Lifescience board will meet on 06 November 2026 to approve the financial results for Q2 FY27.
Oct 30 2026 18:21:45
Supriya Lifescience Ltd - 543434 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Supriya Lifescience updated that the Supreme Court has admitted its pending judicial matter for hearing. The court granted interim relief, directing that no coercive action be taken against the company's directors and officials.
Oct 19 2026 10:42:38
Supriya Lifescience Management
| Name | Position |
|---|---|
| Prachi Sathe | Company Secretary & Compliance Officer |
| Satish Waman Wagh | Chairman |
Supriya Lifescience Similar Stocks
FDC Ltd.
392.25
1.30 (0.33%)
Nephrocare Health Services Ltd.
615.75
-6.60 (1.06%)
Innova Captab Ltd.
1051.60
16.60 (1.60%)
Morepen Laboratories Ltd.
99.71
-1.62 (1.60%)
Senores Pharmaceuticals Ltd.
1186.50
49.50 (4.35%)
IOL Chemicals And Pharmaceuticals Ltd.
190.09
6.32 (3.44%)
Orchid Pharma Ltd.
889.55
12.80 (1.46%)
SMS Pharmaceuticals Ltd.
527.85
2.35 (0.45%)
Sahajanand Medical Technologies Ltd.
512.00
26.10 (5.37%)
Artemis Medicare Services Ltd.
303.00
2.75 (0.92%)
Supriya Lifescience FAQs
The Buying Price of Supriya Lifescience share is 880.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Supriya Lifescience stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Supriya Lifescience, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Supriya Lifescience shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Supriya Lifescience shares is 0. Useful to assess the stock's value relative to its book value.
To assess Supriya Lifescience’s valuation compare Sector P/E, P/B which are 40.04 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Supriya Lifescience is 6920.72 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Supriya Lifescience share price is 1085.00 & 545.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Supriya Lifescience belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SUPRIYA
